Concord Medical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	54.73	49.57	42.74	50.66	34.4	19.77
Depreciation & Amortization	85.13	84.58	78.61	75.99	96.25	102.88
Other Amortization	1.65	1.63	0.82	0.43	0.34	0.32
Loss (Gain) From Sale of Assets	-0.33	-0.15	-0.41	-1.69	-9.16	-1.85
Provision & Write-off of Bad Debts	-0.22	1.02	0.17	-0.69	-1.84	-0.13
Other Operating Activities	1.99	3.35	-5.33	3.91	3.63	-2.84
Change in Accounts Receivable	39.74	4.45	9.48	-2.72	6.64	-19.21
Change in Inventory	0.11	-1.43	2.02	3.18	-6.53	0.79
Change in Accounts Payable	-3.2	4.32	-15.14	17.83	0.67	15.41
Change in Unearned Revenue	-	-	-	-	-	-0.45
Change in Other Net Operating Assets	7.09	1.48	0.26	7.66	13.02	-30.66
Operating Cash Flow	186.69	148.83	113.23	154.56	137.42	84.07
Operating Cash Flow Growth	66.26%	31.45%	-26.74%	12.47%	63.47%	-35.86%
Capital Expenditures	-73.88	-74.72	-88.18	-37.46	-21.8	-93.64
Sale of Property, Plant & Equipment	3.71	3.16	4.47	19.84	30.88	35.41
Sale (Purchase) of Intangibles	-1.81	-1.65	-1.51	-0.61	24.19	-0.39
Investment in Securities	-11.7	-22.5	-109	-97.23	-	2.59
Other Investing Activities	3.42	3.38	6.14	5.15	-0.1	1.18
Investing Cash Flow	-79.72	-92.33	-188.08	-110.31	33.17	-54.86
Short-Term Debt Issued	-	-	-	-	-	67.86
Long-Term Debt Issued	-	-	35	-	-	0.02
Total Debt Issued	40.5	-	35	-	-	67.88
Short-Term Debt Repaid	-	-	-	-	-	-76.36
Long-Term Debt Repaid	-	-24.69	-22.11	-19.58	-120.69	-27.98
Total Debt Repaid	-27.34	-24.69	-22.11	-19.58	-120.69	-104.33
Net Debt Issued (Repaid)	13.16	-24.69	12.89	-19.58	-120.69	-36.46
Issuance of Common Stock	-	-	-	-	100	-
Common Dividends Paid	-36.67	-33.33	-33.33	-16.67	-10	-10
Other Financing Activities	-	-	-40.35	40.11	-0.53	-0.06
Financing Cash Flow	-23.51	-58.02	-60.8	3.87	-31.22	-46.52
Net Cash Flow	83.47	-1.51	-135.65	48.11	139.38	-17.31
Free Cash Flow	112.81	74.12	25.05	117.1	115.63	-9.58
Free Cash Flow Growth	115.84%	195.91%	-78.61%	1.27%	-	-
Free Cash Flow Margin	12.46%	8.33%	3.01%	13.17%	15.65%	-1.18%
Free Cash Flow Per Share	3.37	2.21	0.75	3.51	4.61	-0.38
Cash Interest Paid	3.5	3.55	3.52	3.51	4.79	6.2
Cash Income Tax Paid	12.72	10.1	16.6	9.5	4.59	8.53
Levered Free Cash Flow	94.59	54.59	16.19	108.82	121.36	-11.7
Unlevered Free Cash Flow	96.77	56.81	18.39	111.01	124.35	-7.76
Change in Working Capital	43.75	8.82	-3.39	25.95	13.8	-34.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.